Please login to the form below
Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
Large portfolios gives companies room for manoeuvre
FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics
Speech coincides with Biosimilars Action Plan
Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
Bayer's Eylea remains the drug to beat, however
AstraZeneca joins Merck in Brexit stockpiling effort
Says it is increasing stores of medicines by around 20%
Daily brief: Novartis spends big on ezcema, Kite invests, another gene therapy IPO
A round up from pharma, biotech and healthcare
‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’
Brexit means pharma must review its intellectual property rights across Europe
The Gallery
<>A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.
Agency:
HamellProduct:
Maloff ProtectClient:
Glenmark PharmaceuticalsTherapy area:
Infections and Infestations
Agency:
BASTARD . LONDONProduct:
Self PromotionClient:
Self PromotionTherapy area:
Self Promotion
Agency:
VCCP HealthProduct:
SimponiClient:
Merck Sharp & DohmeTherapy area:
Musculo-skeletal Disorders‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’
Brexit means pharma must review its intellectual property rights across Europe
Communiqué Awards 2018 - Photo Gallery
View the 2018 Winners and Photo Galleries
Novartis launch NET cancer community app
Galaxies of Hope aims to provide support to cancer patients
Healthcare Comms appointments
Cuttsy+Cuttsy appoints new director, Porterhouse Medical adds to team and TBWA\WorldHealth London sees Andy Hayley and Dick Dunford return
No results were found
Pharma industry appointments
Destiny Pharma, Silence Therapeutics and Concept Life Sciences add to its teams.
Commentary: Roseanne’s racist tweet and Sanofi’s swift and surprising riposte
Alexander Davies considers the remarkable story of how one company broke with pharma convention to speak out on social media
Trump attempts The Art of the Deal with pharma
Yet incendiary language, bullying and threats rarely lead to a deal
No results were found
Doing more with less: when ‘client-centricity’ matters most
At a time when companies face continued downward pressure on operational expenditure, doing ‘more with less’ is becoming a fact of life
Featured jobs
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Business Unit Head, Medical Communications, London
-
Excellent package
-
Client Services Director - Med Comms
-
Great salary and bebefits
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
Subscribe to our email news alerts
- Brexit rebels win vote on European Medicines Agency alignment
- AstraZeneca joins Merck in Brexit stockpiling effort
- NHS England to Vertex: come clean on Orkambi offer
- Moving annual total (MAT)
- Vyriad inks immunotherapy alliance with Merck/Pfizer
- J&J’s Invokana aces diabetic kidney disease trial, setting up filings
- Random42 win Creativity International Award for Scientific Animation
- Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
- Aurora partners with PIPHealth and taps into patient panels
- FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics
- Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
- OUTiCO growth in multi-channel creates more job openings
PMHub
Quintiles
With a network of more than 27,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize...Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
- About us
- Contact us
- How to advertise
- Site map
- All content copyright © PMGroup Worldwide Ltd 2018
